- •Imbalances in the gut microbiota may lead to the development and progression of diabetes.
- •Sleep disorders are very prevalent in individuals with diabetes and can be related to a worse prognosis for this disease.
- •Probiotics have been linked to improvements in sleep and glucose and high density lipoprotein cholesterol levels.
- •Probiotic supplementation may be considered to control diabetes, enhance metabolic regulation and sleep quality.
In this manuscript, we call attention to the importance of investigating affordable strategies to improve the management of diabetes. Studies indicate that imbalances in the gut microbiota may lead to the development and progression of this disease. At the same time, poor sleep and sleep disorders, which are very prevalent in individuals with diabetes, can be related to a worse prognosis for the disease and can be impacted by changes in the intestinal microbiome. A suggested treatment that may be effective in controlling diabetes and improving sleep quality through increased metabolic regulation is probiotic supplementation. Scientific evidence has shown a relationship between the use of probiotics and improvements in sleep, in glucose concentrations, and in the levels of high density lipoprotein cholesterol. We suggest that probiotic supplementation can play an important role in the management of diabetes and sleep disorders in diabetic patients. Further randomized clinical studies should be undertaken to better understand the impact and effectiveness of the use of probiotics in improving sleep and controlling diabetes.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Primary Care Diabetes
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- WHO Global report on diabetes: a summary.Int. J. Noncommun. Dis. 2016; 1: 3-8
World Health Organization, Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases: Report of the 2019 Global Survey, 2020.
- The epidemiology of sleep and diabetes.Curr. Diabetes Rep. 2018; 18: 82
- The reciprocal interaction between sleep and type 2 diabetes mellitus: facts and perspectives.Braz. J. Med. Biol. Res. 2008; 41: 180-187
- Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies.Diabetes Care. 2015; 38: 529-537
- From role of gut microbiota to microbial-based therapies in type 2-diabetes.Infect. Genet. Evol. 2020; 104268
- Beyond gut microbiota: understanding obesity and type 2 diabetes.Hormones. 2015; 14: 358-369
- Characterization of the gut microbiota of individuals at different T2D stages reveals a complex relationship with the host.Microorganisms. 2020; 8: 94
- The gut microbiome and the brain.J. Med. Food. 2014; 17: 1261-1272
- Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice.Sci. Rep. 2016; 6: 35405
- The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: a randomized placebo controlled trial.Diabetes Metab. Syndr. 2019; 13: 175-182
- Effects of probiotics on cognitive reactivity, mood, and sleep quality.Front. Psychiatry. 2019; 10
- Risk and safety of probiotics.Clin. Infect. Dis. 2015; 60: S129-S134
- Guidelines for the Evaluation of Probiotics in Food.FAO/WHO, London, ON2002
Published online: February 11, 2023
Accepted: January 31, 2023
Received: March 11, 2022
© 2023 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.